Boehringer ends development of Alzheimer’s candidate
admin 12th February 2018 Uncategorised 0Boehringer Ingelheim is ending development of BI 409306 in Alzheimer’s disease on disappointing mid-stage trial data.
More: Boehringer ends development of Alzheimer’s candidate
Source: News